苏卡波制药(SCMP)

2018年1月FDA审批新药所属上市公司及其股票

药渡2017-12-31 21:54

2018年即将到来，由于特朗普减税计划的搅动，这一年的制药行业注定不会平静。同时，FDA对新药申请的审批，也对药企的股价产生影响，新一轮并购、重组正在酝酿之中。现在我们来盘点一下FDA在1月份即将审批的新药所属美国上市生物技术公司及股票，看看可以从中发现什么商机吧。
Lipocine
FD...查看全文

年底大并购：12亿美元三个药及债务

药渡2017-12-28 22:28

随着特朗普减税计划的实施，预测2018年将是一个药企并购大年，目前这场大战已提前打响。近日，Mallinckrodt宣布以12亿美元收购Sucampo，并得到一种上市药物——治疗便秘的Amitiza，以及两种已经处于研发后期的罕见病新药。
Mallinckrodt今年初退出美国药物研究和制造商(协会)后，实行了一系列...查看全文

canthree2017-02-18 20:32

$Sucampo Pharmaceuticals (SCMP)$ 当天卖掉盘后大涨 查看全文

hll88482016-11-29 00:36

$Sucampo Pharmaceuticals (SCMP)$ - new high is coming[看多]查看全文

hll88482016-11-26 03:03

$Sucampo Pharmaceuticals (SCMP)$ - today is Blackfriday, most of stocks have very little trade volume, but we see this one with increasing volume compared to last 5 days ave.volume. something fishy is going on. buy buy buy!!![看多]查看全文

PPT金融一周周报

疯狂期权FO2015-08-31 08:45

报告作者：Michael 报告出处：PPT金融
相关股票：$标普500指数ETF-SPDR(SPY)$ $纳斯达克综合指数(NASDAQ)$ $道琼斯指数(DJI30)$ $Netflix(NFLX)$ $Sucampo Pharmaceuticals (SCMP)$
8月24日开始至8月29日结束的一周周评，及下周的展望.
网页链接查看全文

Sucampo Pharmaceuticals 的评级信息汇总

深思远见2015-07-13 06:04

$Sucampo Pharmaceuticals (SCMP)$近期评级信息如下：
20150708 Maxim Group 重申相同投资评价， 评级：买入， 目标价：$20.00
更多分析和资讯，请关注微-信-公-众-号 stock_tong查看全文

Keats2015-03-27 10:06

$Sucampo Pharmaceuticals (SCMP)$ 上季度销售+54%，盈利+250%，本季度预期+500%，本年度预期+48%，连续两个季度盈利加速，基金连续两个季度增持查看全文

$Sucampo Pharmaceuticals (SCMP)$ 美东时间 2017-03-08 盘前 披露财报，预期EPS 0.49 网页链接

$Sucampo Pharmaceuticals (SCMP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-14 AccNo: 0001193125-17-043686 Size: 31 KB 网页链接

$Sucampo Pharmaceuticals (SCMP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-08 AccNo: 0000215457-17-002819 Size: 12 KB 网页链接

$Sucampo Pharmaceuticals (SCMP)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-01-30 AccNo: 0000215457-17-002692 Size: 13 KB 网页链接

$Sucampo Pharmaceuticals (SCMP)$ 8-K - Current report Filed: 2017-01-09 AccNo: 0001171843-17-000143 Size: 2 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

$Sucampo Pharmaceuticals (SCMP)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2016-12-29 AccNo: 0001193125-16-807408 Size: 39 KB 网页链接

$Sucampo Pharmaceuticals (SCMP)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2016-12-29 AccNo: 0001193125-16-807403 Size: 55 KB 网页链接

$Sucampo Pharmaceuticals (SCMP)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2016-12-29 AccNo: 0001193125-16-807395 Size: 55 KB 网页链接

$Sucampo Pharmaceuticals (SCMP)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-12-29 AccNo: 0001193125-16-807385 Size: 25 KB 网页链接

$Sucampo Pharmaceuticals (SCMP)$ 8-K - Current report Filed: 2016-12-27 AccNo: 0001193125-16-803950 Size: 558 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of...